Hemolytic anemia is a disorder where the body destroys red blood cells (RBCs), which are removed from the system before their normal life span of 120 days is over. Destruction of red blood cells is ...

THE absence of anemia in infectious mononucleosis is generally accepted. Indeed, this fact is useful as an aid in the differential diagnosis of infectious mononucleosis and leukemia. Bernstein 1 has ...

The following report presents 3 cases of intravascular hemolysis that followed aortic-valve replacement with cusps composed of Dacron cloth impregnated with silicone rubber. 8,9 Hematologic data on 32 ...

Q: Which doctor treats hemolytic anemia? A: Hemolytic anemia is usually diagnosed by a family physician or a pediatrician, who may refer the patient to a hematologist. A: Small red blood cells, also ...

Additional population-based studies of autoimmune hemolytic anemia and its management are needed to reduce mortality in this patient population. Autoimmune hemolytic anemia (AIHA) is typically a ...

Mihir Raval, MD, MPH, comments on the difference between cold agglutinin disease and other autoimmune hemolytic anemias. Neil Minkoff, MD: Now, you had mentioned that there are other autoimmune ...

Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

Researchers are seeking pregnant patients for the clinical trial of a drug designed to decrease the risk of fetal anemia in patients with hemolytic disease of the fetus and newborn (HDFN).

In the era of Rhesus (Rh) immune globulin treatment, the non-D Rh antibodies are an increasingly significant cause of alloimmune hemolytic disease of the newborn (HDN). 1 While HDN due to anti-e has ...

Polychromasia refers to the different colors your red blood cells (RBCs) appear under a microscope. It's not a diagnosis but anemia, infection, blood loss, or cancer can cause polychromasia. These ...

Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...